Principal Investigator


Ken Arnold

As a museum director and scholar, Professor Ken Arnold’s work in reNEW focuses on mobilizing the University of Copenhagen’s Medical Museion as a hub for research, stakeholder understanding and public engagement in the area of stem cell medicine.

Professor Ken Arnold
Ken Arnold
Location: UCPH, Denmark
See ORCID Profile
Personal website

Professor Ken Arnold is an international leader in the museum sector with over 30 years of experience in directing and investigating museums. He now focuses on developing the role of the University of Copenhagen’s (UCPH) research museum, the Medical Museion.

Professor Arnold aims to make the Medical Museion a “platform for social engagement,” a place where patient-orientated research and engagement in stem cell topics for interest groups and targeted groups of the public takes place. This approach will be explored in reNEW’s other nodes – Leiden and Melbourne – where collaborations with cultural institutional partners within academia and beyond are planned.

Professor Arnold is principal investigator at the reNEW Centre for Stem Cell Medicine’s PREPARE team in Copenhagen and the director of the Medical Museion. He is also professor in public health at the UCPH.

Prior to joining the academic work, Professor Arnold worked as head of cultural partnerships at the Wellcome Trust in London, where he directed co-produced international cultural programs and the creative vision of the Wellcome Collection that opened in 2007. He holds a PhD in history from Princeton University, USA, and diploma in museum studies from Leicester University, UK.


reNEW researchers have a strong track record of scientific excellence in stem cell biology

They have performed pioneering work in stem cell research spanning different tissue and cell types, different technological advances and different stages of applied research. This provides an unprecedented international opportunity to utilise the combined wealth of knowledge, complementary skills sets and clinical experience across reNEW to push stem cell discoveries toward translational outcomes.